SEC Form 4 · accession 0001140361-15-017421

VASCULAR SOLUTIONS INC · VASC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Apr 30, 2015

Accepted (ET)

May 4, 2015 · 4:39 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001030206

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Apr 30, 2015	F	1,069	$32.06	D	69,210	D
Common Stock^F2	May 1, 2015	A	2,298	—	A	71,508	D
Common Stock^F1	holding	—	—		—	500	I	Owned by spouse.
Common Stock	holding	—	—		—	70,279	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$7.88	holding	—	—	—	—	Apr 18, 2016	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$9.41	holding	—	—	—	—	Apr 24, 2017	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$6.36	holding	—	—	—	—	Apr 22, 2018	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$6.39	holding	—	—	—	—	Apr 21, 2019	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$9.61	holding	—	—	—	—	Apr 22, 2020	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$11.72	holding	—	—	—	—	Apr 22, 2021	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$11.63	holding	—	—	—	—	May 4, 2022	Common Stock	10,000	10,000	D

F1Reporting person holds 500 shares indirectly and disclaims beneficial ownership of these shares.
F2Represents restricted stock award that shall become 100% fully vested on May 1, 2016, subject to continuation of service as a Director of the Company.
F3100% fully vested.